report result januari
review assumpt underpin key oper driver result
minor earn upgrad npat discount cash flow-
deriv target price increas maintain
neutral rate forecast revenu growth constant
currenc report note higher eurusd vs
pcp forecast ebitda vs pcp assum modest
improv oper leverag non-gaap npat forecast
impli growth pcp
expect market share gain mask tougher futur comp three
cpap manufactur cite market share win new patient set-up
recent commentari fph suggest like
beneficiari market share movement nasal full face mask
forecast strong quarter us mask growth remain
doubl digit fall back singl digit due
cycl tougher comp remain wari potenti irrat asp
discount key competitor struggl maintain share osa mask
scenario asp discount remain modest believ
dme re-suppli need pick current level order
sustain us mask growth
catalyst result januari re-commenc
risk includ protract competitor litig escal asp
discount potenti upsid forecast could aris better
oper cost leverag sg us tax reform
valuat current trade forward consensu
earn repres premium rel industri ex-
financi vs two-year averag respect
valuat metric
chang previou ep
price month
total return forecast perspect
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
price book
return equiti
return asset
return invest cap
net debt ebitda
capital-expenditure sale
capital-expenditure depr
price jan rate neutral target price analyst gretel janu
profit tax
profit tax
unusu item tax
chang work capit
cash non-cash item
movement cash/equival
 asx close
spot exchang rate
report result tuesday januari review
assumpt key oper forecast
us flow gener growth continu broaden copd
forecast us flow gener growth figur ahead
estim market growth rate new patient set-up strong comp
expect small contribut airmini commenc
ship us may
recent announc launch -brand portabl oxygen
concentr poc mobi broaden copd product exposur initi
sold dme channel us market seek clearanc
sell countri expect launch provid small uplift
growth albeit lower gross margin group
us mask look double-digit growth
forecast us mask sale growth figur view
industri averag note weak comp three cpap
manufactur cite market share win new patient set-up recent
commentari fph suggest like beneficiari market share
movement nasal full face mask
figur mask growth expect decreas
chart compani data credit suiss estim
product mix implic gross margin
note balanc growth rate us product last quarter
figur figur howev flow gener still contribut us
base rel growth rate forecast similar contribut mask
total us revenu vs result gross margin forecast remain flat
sequenti
figur product mix skew gener
us revenu composit product
chart compani data credit suiss estim
forecast row flow gener growth constant currenc figur
cycl cc growth translat report growth due
appreci eurusd vs pcp
row mask growth continu mask sale roll-out
forecast row mask sale growth constant currenc figur
translat report growth expect continu strong growth mask
sale roll new product continu share shift
figur gener sale growth
figur mask growth doubl digit
chart compani data credit suiss estim
total forecast group revenu includ brightre revenu
report constant currenc vs pcp
forecast gross margin figur flat sequenti
pcp driven mix
figur highli correl us mask sale
mask share total us sale group gross margin
chart compani data credit suiss estim
mask total us sale
sell gener admin expens
forecast sg cost growth vs pcp
repres revenu vs pcp within manag guidanc
rang
research develop expens
forecast cost growth vs pcp repres
revenu consist manag guidanc
figur costs/sal expect stabl
proport sale
figur cog largest cost
made minor adjust oper assumpt across key revenu line
fx result small earn chang npat upgrad averag
figur aud-deriv target price increas
oper earn forecast shown figur
good sold
research develop
current trade forward consensu earn repres
premium rel industri ex-financi vs two-year averag
respect
figur strong price-to-earnings re-rat last month
figur price-to-earnings rel well histor averag
pe rel industri ex-financi
chart bloomberg compani data credit suiss estim
new total return forecast perspect chart help visual credit suiss consensu view compani return within
context forecast risk histor trade pattern
volatil calcul annualis standard deviat weekli total return seri past month illustr variabl
stock return word risk way think one would rather take forecast return stock volatil
stock volatil shade area show one standard deviat rang base past month volatil statist
term make number brave assumpt probabl share price end insid rang month
hi-lo maximum minimum daili close price past week often handi know price momentum especi
stock trade close high low stock trade close peak momentum stock
consensu consensu suppli thomson reuter survey sell side research analyst collect dozen data
point ep dp sale target price roe mean averag target return shade area around mean
repres rang estim lowest highest estim aid visualis number import factor rang
analyst estim credit suiss estim stock sit rel consensu share price rel consensu
mean consensu rang target
return calcul capit gain plu forecast dividend yield net next month cs tgt use credit suiss
target price credit suiss forecast forward dividend gross frank consensu mean rang use
consensu target price consensu dividend forecast month forward
compani mention price
